1. Home
  2. XOMA vs LPAA Comparison

XOMA vs LPAA Comparison

Compare XOMA & LPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XOMA
  • LPAA
  • Stock Information
  • Founded
  • XOMA 1981
  • LPAA 2024
  • Country
  • XOMA United States
  • LPAA United States
  • Employees
  • XOMA N/A
  • LPAA N/A
  • Industry
  • XOMA Biotechnology: Pharmaceutical Preparations
  • LPAA
  • Sector
  • XOMA Health Care
  • LPAA
  • Exchange
  • XOMA Nasdaq
  • LPAA Nasdaq
  • Market Cap
  • XOMA 250.1M
  • LPAA 290.4M
  • IPO Year
  • XOMA N/A
  • LPAA 2024
  • Fundamental
  • Price
  • XOMA $19.30
  • LPAA $10.20
  • Analyst Decision
  • XOMA Strong Buy
  • LPAA
  • Analyst Count
  • XOMA 2
  • LPAA 0
  • Target Price
  • XOMA $72.00
  • LPAA N/A
  • AVG Volume (30 Days)
  • XOMA 30.1K
  • LPAA 46.2K
  • Earning Date
  • XOMA 03-17-2025
  • LPAA 01-01-0001
  • Dividend Yield
  • XOMA N/A
  • LPAA N/A
  • EPS Growth
  • XOMA N/A
  • LPAA N/A
  • EPS
  • XOMA N/A
  • LPAA N/A
  • Revenue
  • XOMA $28,487,000.00
  • LPAA N/A
  • Revenue This Year
  • XOMA $29.60
  • LPAA N/A
  • Revenue Next Year
  • XOMA $34.18
  • LPAA N/A
  • P/E Ratio
  • XOMA N/A
  • LPAA $47.69
  • Revenue Growth
  • XOMA 498.72
  • LPAA N/A
  • 52 Week Low
  • XOMA $19.12
  • LPAA $9.66
  • 52 Week High
  • XOMA $35.00
  • LPAA $10.22
  • Technical
  • Relative Strength Index (RSI)
  • XOMA 27.79
  • LPAA N/A
  • Support Level
  • XOMA $20.45
  • LPAA N/A
  • Resistance Level
  • XOMA $21.45
  • LPAA N/A
  • Average True Range (ATR)
  • XOMA 0.80
  • LPAA 0.00
  • MACD
  • XOMA 0.05
  • LPAA 0.00
  • Stochastic Oscillator
  • XOMA 6.49
  • LPAA 0.00

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

About LPAA Launch One Acquisition Corp. Class A Ordinary shares

Launch One Acquisition Corp is a blank check company.

Share on Social Networks: